Pain relief concept

Beyond the Block: Is the MTP Block a Game-Changer for Post-Thoracoscopic Pain?

Reese Marlowe in Health & Wellness November 2026 • 4 min read.

"A novel approach to pain management after video-assisted thoracoscopic surgery (VATS) is under investigation."

Video-assisted thoracoscopic surgery (VATS) has become a standard approach for many thoracic procedures, but effective postoperative pain management remains a challenge. Traditional methods like epidural analgesia and thoracic paravertebral blocks (PVB) have potential drawbacks, including complications and limited suitability for high-risk patients.

A recent letter to the editor in 'Minerva Anestesiologica' explores a promising alternative: the mid-point transverse process to pleura (MTP) block. This novel technique aims to provide effective analgesia while potentially reducing the risks associated with conventional methods.

The MTP block involves injecting local anesthetic at the midpoint between the transverse process and pleura, targeting the paravertebral space. The authors propose that this approach may offer a simpler, safer option with a lower risk of pleural puncture and neurovascular injury.

AI Search Multiple angles on this topic

Stats & Impact

Evidence Remains Unclear

The available material does not provide statistics on MTP blocks or post-thoracoscopic pain. As a result, the block's effect on pain, recovery, and complications cannot be quantified here. Any conclusion about its impact should therefore remain appropriately cautious.

Standard Approach

Methods Require Direct Evidence

The provided material does not describe standard analgesic methods after thoracoscopy or their limitations. It therefore cannot establish how MTP blocks compare with accepted approaches. Direct clinical evidence would be needed to make a reliable comparison.

History

A National Park History, Not a Clinical One

The supplied historical sources concern Yosemite National Park rather than thoracic anesthesia. Yosemite preserves wilderness on the west slope of California's central Sierra Nevada Mountains, and the park includes three giant-sequoia groves with about 500 mature trees in Mariposa Grove. The sources also report that Yosemite welcomes more than four million visitors annually, but they provide no milestones or foundational discoveries related to MTP blocks.

MTP Block: A Simpler, Safer Alternative for VATS Analgesia?

Pain relief concept

The authors detail a case where the MTP block was successfully used for postoperative pain management in a patient undergoing VATS lobectomy. A combination of ropivacaine, fentanyl, and acetaminophen was administered during and after the procedure. Postoperatively, the patient reported a sensory block in the T3-T7 dermatomes on the right side, with good analgesia and a pain score of less than 4 on the Numeric Rating Scale.

The case suggests that the MTP block may represent a viable alternative to traditional regional techniques for VATS lobectomy. Here's a comparison of key considerations:

Efficacy: The MTP block provided effective pain relief in the reported case, comparable to PVB.
Safety: By targeting the midpoint between the transverse process and pleura, the MTP block may reduce the risk of pleural puncture.
Simplicity: The MTP block may be technically easier to perform than PVB, potentially lowering the learning curve for practitioners.
Patient Suitability: The MTP block may be a suitable option for patients in whom epidural analgesia or PVB are contraindicated or considered high-risk.

AI Search Multiple angles on this topic

Latest Research

The Supplied Research Concerns Music

The listed sources discuss Led Zeppelin rather than MTP blocks or post-thoracoscopic pain. They report that the band first toured the United Kingdom as the New Yardbirds on October 4, 1968, and that its first show as Led Zeppelin took place on October 25, 1968. The debut album, recorded at Olympic Studios in London in September and October 1968, was released in the United States in January 1969 and in the United Kingdom on March 31, 1969; none of these sources provides a medical research finding.

Counterpoints

No Clinical Counterarguments Supplied

The available material does not identify failed MTP-block studies, adverse outcomes, or counterarguments about its use after thoracoscopy. It therefore cannot support a specific criticism or estimate of treatment failure. Those issues would require sources directly addressing clinical outcomes.

Comparison

No Direct Comparison Available

The provided material does not compare MTP blocks with other post-thoracoscopic pain strategies. It consequently cannot establish relative effectiveness, safety, duration, or resource requirements. Any comparative conclusion would be speculative without directly relevant studies.

Despite these potential advantages, the authors emphasize that further investigation is necessary to confirm the real effectiveness of this technique and elucidate its enigma.

The Future of Pain Management in VATS

The MTP block represents a promising step forward in the ongoing effort to optimize pain management after VATS. While further research is needed to fully understand its effectiveness and safety profile, this novel technique has the potential to improve patient outcomes and reduce the risks associated with traditional methods. As the field of regional anesthesia continues to evolve, innovative approaches like the MTP block may play an increasingly important role in providing comprehensive, patient-centered care.

AI Search Multiple angles on this topic

Expert View

Furniture Listings Do Not Provide Clinical Commentary

The supplied sources are retail listings for chevron accent chairs, not expert commentary on MTP blocks. They describe products including a Homelegance chair with soft corduroy upholstery, a solid rubberwood frame, a natural weathered finish, and a matching pillow. These listings offer no evidence about thoracic analgesia or post-thoracoscopic recovery.

Future Outlook

Technology Forums, Not Clinical Forecasts

The listed sources discuss home-media technology rather than the future of MTP blocks. One Plex forum explains a transcoder throttle buffer as the amount of time buffered before throttling, while other entries discuss file naming, metadata, thumbnails, and streaming devices such as Slingbox and TiVo. These materials do not support predictions about future regional-anesthesia research or clinical adoption.

Broader Context

System Context Cannot Be Inferred

The supplied sources describe Microsoft as an American multinational technology company headquartered in Redmond, Washington. They mention its work across Windows, internet services, cloud computing, artificial intelligence, gaming, and productivity software. They do not address healthcare systems, access to regional anesthesia, or systemic challenges affecting MTP-block use.

Real-World Impact

Patient Impact Requires Relevant Evidence

The provided material does not describe patients' experiences with MTP blocks or the real-world effects of post-thoracoscopic pain. It therefore cannot support claims about comfort, mobility, satisfaction, or quality of life. Relevant patient-centered clinical sources would be needed for a grounded discussion.

A network meta-analysis reported a reduction in opioid consumption for TPVB relative to control, placing that technique in a different comparison from the direct MTPB-versus-TPVB reports.^[1]

A separate report describes persistent moderate-intensity pain beyond six months after VATS, giving a longer-term context that acute postoperative comparisons do not address.^[2]

What remains to be established about MTP blocks

Would direct comparisons show whether differences in pain relief, analgesic use, complications, and satisfaction persist across settings, given that one comparison found no statistical differences across those outcomes?^[2]
How much confidence should be placed in pain-score comparisons when evidence quality ranges from very low to moderate?^[3]
Do sensory coverage patterns seen with intertransverse process blocks help explain clinical pain outcomes, given the reported reduction in blocked anterior thoracic dermatomes over time?^[4]

Terms behind the comparisons

GRADE: Evidence-quality rating approach^[3]

Sources

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is the Mid-Point Transverse Process to Pleura (MTP) block?

The Mid-Point Transverse Process to Pleura (MTP) block is a novel approach to pain management that is being investigated for use after video-assisted thoracoscopic surgery (VATS). It involves injecting a local anesthetic at the midpoint between the transverse process and pleura, with the aim of targeting the paravertebral space. The MTP block is proposed as a simpler and potentially safer alternative to traditional pain management methods such as epidural analgesia and thoracic paravertebral blocks (PVB).

2

How does the MTP block compare to other pain management methods like epidural analgesia and the thoracic paravertebral block (PVB) for VATS procedures?

Compared to traditional methods such as epidural analgesia and thoracic paravertebral blocks (PVB), the MTP block presents potential advantages. The MTP block may be simpler to perform, potentially reducing the learning curve for practitioners. Safety may be improved because the MTP block targets the midpoint between the transverse process and pleura, potentially lowering the risk of pleural puncture and neurovascular injury, risks associated with PVB. However, it is important to note that the benefits of the MTP block are still under investigation, and further research is needed to confirm its effectiveness and safety profile.

3

What are the potential benefits of using the MTP block for pain management after VATS lobectomy?

The MTP block may offer several potential benefits for pain management following video-assisted thoracoscopic surgery (VATS) lobectomy. It could provide effective analgesia, comparable to that of thoracic paravertebral blocks (PVB). The MTP block's technique might reduce the risk of complications such as pleural puncture and neurovascular injury, as it targets a specific anatomical location. Furthermore, it may be a suitable option for patients for whom epidural analgesia or PVB are not appropriate. The simplicity of the MTP block may also be a significant advantage, as it could make the procedure easier to perform.

4

What kind of drugs were used in the MTP block case discussed?

In the reported case, a combination of ropivacaine, fentanyl, and acetaminophen was administered during and after the Mid-Point Transverse Process to Pleura (MTP) block procedure. This combination was used to provide postoperative pain management for a patient undergoing VATS lobectomy. The patient experienced a sensory block in the T3-T7 dermatomes on the right side, indicating effective pain relief.

5

What are the key considerations when evaluating the MTP block for VATS analgesia?

When evaluating the Mid-Point Transverse Process to Pleura (MTP) block for video-assisted thoracoscopic surgery (VATS) analgesia, key considerations include efficacy, safety, simplicity, and patient suitability. Efficacy refers to the block's ability to provide effective pain relief, safety addresses the potential risks, and simplicity assesses the technical ease of performing the block. Patient suitability determines if the MTP block is a viable option for specific patients, especially those for whom traditional methods like epidural analgesia or thoracic paravertebral blocks (PVB) are not appropriate or carry higher risks. It is important to acknowledge that while promising, further research is required to confirm these aspects and fully understand the benefits of the MTP block.